AGE0 Stock Overview
Develops, produces, and distributes various analog and digital imaging systems worldwide. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AGE0 from our risk checks.
Agfa-Gevaert NV Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.27 |
52 Week High | €3.12 |
52 Week Low | €1.27 |
Beta | 0.69 |
11 Month Change | -38.94% |
3 Month Change | -43.81% |
1 Year Change | -59.29% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -84.03% |
Recent News & Updates
Recent updates
Shareholder Returns
AGE0 | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | -12.4% | 0.05% | 0.2% |
1Y | -59.3% | -32.1% | 8.5% |
Return vs Industry: AGE0 underperformed the German Healthcare Services industry which returned -32.1% over the past year.
Return vs Market: AGE0 underperformed the German Market which returned 8.5% over the past year.
Price Volatility
AGE0 volatility | |
---|---|
AGE0 Average Weekly Movement | 6.7% |
Healthcare Services Industry Average Movement | 5.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: AGE0 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: AGE0's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1867 | 4,819 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
AGE0 fundamental statistics | |
---|---|
Market cap | €103.73m |
Earnings (TTM) | -€32.00m |
Revenue (TTM) | €1.13b |
0.1x
P/S Ratio-3.2x
P/E RatioIs AGE0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AGE0 income statement (TTM) | |
---|---|
Revenue | €1.13b |
Cost of Revenue | €774.00m |
Gross Profit | €352.00m |
Other Expenses | €384.00m |
Earnings | -€32.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.21 |
Gross Margin | 31.26% |
Net Profit Margin | -2.84% |
Debt/Equity Ratio | 0% |
How did AGE0 perform over the long term?
See historical performance and comparison